Prior to founding Spiriplex, Inc. in 2013, David spent 18 years in the clinical laboratory and medical diagnostics industry. His wealth of experience included roles as head of product development and President of Biosafe Laboratories and as CEO of Healthpoint Diagnostix. In this span, Dave and the enterprises he led, established significant joint ventures in the diagnostics arena with a number of health care clients including Novartis, Genentech, Grifols, Grifols Canada, CSL Behring, Johnson and Johnson, Bristol Myers and Amgen. Since 1999, he has also been co-owner and Chairman of Belle Holdings, Inc., a Nebraska healthcare company. Prior to entering the healthcare field in 1996, Mr. Fleisner was a former associate of a privately held financial planning and investment advisory firm. Dave has a B.S. Degree in Finance from the University of Illinois at Chicago.
